• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产碳青霉烯酶肠杆菌科在外科重症监护病房爆发的经济影响。

Economic impact of an outbreak of carbapenemase producing-Enterobacteriaceae in a surgical intensive care unit.

机构信息

APHP, CHU Bichat-Claude Bernard, Département d'Anesthésie Réanimation, 46 rue Henri Huchard, 75018 Paris, France.

APHP, CHU Bichat-Claude Bernard, Unité d'Hygiène et de Lutte contre les Infections Nosocomiales, 46 rue Henri Huchard, 75018 Paris, France.

出版信息

Anaesth Crit Care Pain Med. 2022 Aug;41(4):101093. doi: 10.1016/j.accpm.2022.101093. Epub 2022 Apr 30.

DOI:10.1016/j.accpm.2022.101093
PMID:35504523
Abstract

BACKGROUND

A 15-month outbreak of carbapenemase-producing Enterobacterales (CPE) occurred in the surgical intensive care unit (SICU) of our institution. We aimed to estimate the financial impact of this outbreak from the perspective of the French public health insurance system.

METHODS

The characteristics of the colonised/infected CPE patients and outbreak management according to French national guidelines were prospectively collected. Loss of productivity was assessed in terms of the reduction in total number of admissions (TNA) and discharges and in ICU length of stay (LoS). The additional financial burden associated with this outbreak was estimated by the accounting department of the hospital, including the impact of the extended LoS and restricted admissions.

RESULTS

Sixteen CPE patients (19 stays) were hospitalised in the SICU (10/2016-01/2018). The median ICU LoS for the CPE cases was 17 [8-36] days versus 6.5 and 6.1 days in 2016 and 2017, respectively, for the whole SICU population. The total number of lost bed days during the outbreak was 452. The TNA dropped dramatically in 2017 (decrease of 20.6%). The estimated costs were 768,386 EUR for bed days lost; 297,176 EUR and 63,675 EUR for the extended LoS for the CPE cases and the patients on contact precautions, respectively; 34,045 EUR for staff reinforcements; 85,764 EUR for bacteriological screening tests; and 42,857 EUR for antimicrobial treatment. The total financial burden of the outbreak was 1,291,903 EUR.

CONCLUSION

Management of a CPE outbreak in the SICU is associated with a huge financial burden for the unit and for the institution.

摘要

背景

本机构外科重症监护病房(SICU)发生了为期 15 个月的碳青霉烯酶肠杆菌科(CPE)爆发。我们旨在从法国公共卫生保险体系的角度评估此次爆发的经济影响。

方法

前瞻性收集了定植/感染 CPE 患者的特征以及根据法国国家指南进行的爆发管理情况。通过减少总入院人数(TNA)和出院人数以及 ICU 住院时间(LoS)来评估生产力损失。医院会计部门估算了与此次爆发相关的额外财务负担,包括延长的 LoS 和受限的入院对其的影响。

结果

16 例 CPE 患者(19 例住院)在 SICU 住院(2016 年 1 月至 2018 年 1 月)。CPE 病例的 ICU 中位 LOS 为 17 [8-36] 天,而 2016 年和 2017 年整个 SICU 人群的中位数分别为 6.5 和 6.1 天。爆发期间总失床日数为 452 天。2017 年 TNA 急剧下降(减少 20.6%)。估计损失的床位日数为 768,386 欧元;CPE 病例和接触预防措施患者的延长 LOS 分别为 297,176 欧元和 63,675 欧元;人员增援 34,045 欧元;细菌学筛查试验 85,764 欧元;抗菌治疗 42,857 欧元。此次爆发的总经济负担为 1,291,903 欧元。

结论

SICU 中 CPE 爆发的管理给科室和机构带来了巨大的经济负担。

相似文献

1
Economic impact of an outbreak of carbapenemase producing-Enterobacteriaceae in a surgical intensive care unit.产碳青霉烯酶肠杆菌科在外科重症监护病房爆发的经济影响。
Anaesth Crit Care Pain Med. 2022 Aug;41(4):101093. doi: 10.1016/j.accpm.2022.101093. Epub 2022 Apr 30.
2
Intra-Abdominal Infections by Carbapenemase-Producing in a Surgical Unit: Counting Mortality, Stay, and Costs.产碳青霉烯酶肠杆菌科细菌引起的腹腔内感染:病死率、住院时间和费用的计算。
Surg Infect (Larchmt). 2021 Apr;22(3):266-273. doi: 10.1089/sur.2020.137. Epub 2020 Jun 26.
3
Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.外科重症监护病房入院时产碳青霉烯酶肠杆菌科细菌定植的危险因素:一项回顾性研究。
Enferm Infecc Microbiol Clin. 2017 Jun-Jul;35(6):333-337. doi: 10.1016/j.eimc.2016.02.017. Epub 2016 Mar 22.
4
Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).产碳青霉烯酶肠杆菌携带者的特征与成本(2012/2013年)
Med Mal Infect. 2014 Jul;44(7):321-6. doi: 10.1016/j.medmal.2014.06.004. Epub 2014 Jul 9.
5
Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective.从医院角度评估产碳青霉烯酶肠杆菌科细菌暴发的成本:一项经济评价。
Clin Microbiol Infect. 2017 Mar;23(3):188-196. doi: 10.1016/j.cmi.2016.10.005. Epub 2016 Oct 13.
6
Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.运用美国疾病控制与预防中心2012年耐碳青霉烯类肠杆菌科细菌工具包中所倡导的干预措施,控制重症监护病房内产碳青霉烯酶肠杆菌科细菌和广泛耐药鲍曼不动杆菌感染的同时暴发。
Infect Control Hosp Epidemiol. 2014 Jul;35(7):810-7. doi: 10.1086/676857. Epub 2014 May 15.
7
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.某大学医院 ICU 和 HSCT 病房高危患者中产碳青霉烯酶肠杆菌科直肠定植的流行病学和危险因素。
Antimicrob Resist Infect Control. 2020 Sep 23;9(1):155. doi: 10.1186/s13756-020-00816-4.
8
Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.急性环境中碳青霉烯酶肠杆菌科爆发的控制:证据回顾。
J Hosp Infect. 2017 Jan;95(1):3-45. doi: 10.1016/j.jhin.2016.10.006. Epub 2016 Oct 14.
9
The impact of enhanced screening for carbapenemase-producing Enterobacterales in an acute care hospital in South Korea.韩国一家急症医院中增强型产碳青霉烯酶肠杆菌科筛查的影响。
Antimicrob Resist Infect Control. 2023 Jul 3;12(1):62. doi: 10.1186/s13756-023-01270-8.
10
Long-term contamination of sink drains by carbapenemase-producing Enterobacterales in three intensive care units: characteristics and transmission to patients.三家重症监护病房中产生碳青霉烯酶的肠杆菌科细菌对水槽排水管道的长期污染:特征及向患者的传播
J Hosp Infect. 2021 Jun;112:16-20. doi: 10.1016/j.jhin.2021.02.016. Epub 2021 Feb 23.

引用本文的文献

1
Carbapenemase-Producing Enterobacterales: An Increasing Threat to Australian Liver Transplant Recipients.产碳青霉烯酶肠杆菌科细菌:对澳大利亚肝移植受者构成的威胁日益增加。
Transpl Infect Dis. 2025 Mar-Apr;27(2):e14432. doi: 10.1111/tid.14432. Epub 2025 Jan 18.
2
Gut microbiota alterations in critically Ill patients with carbapenem-resistant Enterobacteriaceae colonization: A clinical analysis.碳青霉烯类耐药肠杆菌科细菌定植的危重症患者的肠道微生物群改变:一项临床分析。
Front Microbiol. 2023 Apr 4;14:1140402. doi: 10.3389/fmicb.2023.1140402. eCollection 2023.